ADVA ACE Coronary Stent System in Coronary Artery Disease Patients (ADVANCE)

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 110 participants.

Also called NCT07912541

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 110 participants (planned count) (from the registry)
Sponsor
Advanced MedTech Solutions Pvt. Ltd. (from the registry)
Registry
  • NCT NCT07912541
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07912541. Allocation not applicable; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2028-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ADVA ACE Coronary Stent System in Coronary Artery Disease Patients (ADVANCE)
Acronym
ADVANCE
Condition
De Novo Stenosis Lesion
Condition
Coronary Stent Implantation
Intervention (Device)
ADVA ACE Everolimus Eluting Coronary Stent System
Lead sponsor
Advanced MedTech Solutions Pvt. Ltd. (class: other)
Collaborator
Clicebo Solutions Private Limited (class: other)

Record details

Record id
cardio:ct-nct07912541
Content hash
68a24597df15f7b323b50dbcd4884e9b6b69080f2761a72ca5db00bb299f1c99